Distinct Genetically Determined Origins of Myd88/BCL2-Driven Aggressive Lymphoma Rationalize Targeted Therapeutic Intervention Strategies. (2023)
Attributed to:
Mechanisms of mature B-cell tumour pathogenesis and of the interplay between host-immunity and these tumours.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1158/2643-3230.bcd-22-0007
PubMed Identifier: 36346827
Publication URI: http://europepmc.org/abstract/MED/36346827
Type: Journal Article/Review
Volume: 4
Parent Publication: Blood cancer discovery
Issue: 1
ISSN: 2643-3230